8 research outputs found

    3D ν”„λ¦°νŒ…μ„ μ΄μš©ν•œ ν•­μƒμ œ 방좜 식도 패치의 쑰직 μž¬μƒ νš¨κ³Όμ— λŒ€ν•œ 연ꡬ

    Get PDF
    ν•™μœ„λ…Όλ¬Έ(박사) -- μ„œμšΈλŒ€ν•™κ΅λŒ€ν•™μ› : μ˜κ³ΌλŒ€ν•™ μ˜ν•™κ³Ό, 2021.8. μ •μ€μž¬.Esophageal defects can cause exposure of the fistula site to various bacterial species, which could lead to a severe inflammatory response. We designed and manufactured a 3D-printed patch consisting of a lattice pattern and thin-film with biodegradable polycaprolactone (PCL), that released the antibiotic, tetracycline (TCN). We reconstructed an artificial defect in the rat esophagus using this patch. The efficacy and availability of 3D-printed antibiotic-releasing patches were evaluated using both quantitative and qualitative assessment methods. PCL was used to print the lattice pattern on a pre-manufactured thin film with approximately 100ΞΌm resolution, which had been mixed with tetracycline (TCN) at 100Β°C and 1000Β°C to release the antibiotic evenly. In vitro tests showed that TCN was released for more than 1 month. In addition, in vitro cytotoxicity test demonstrated excellent cell compatibility. 3D-printed antibiotic-releasing patches were applied on the defect sites after creating artificial partial esophageal defects in rats. Four weeks after the surgery, leakage was checked using micro-computed tomography with an oral contrast agent injected into the rat mouth. No leakage was evident in any part of the esophagus. For analyzing tissue regeneration, immunohistochemistry was performed. M1 and M2 macrophage activation was verified by immunohistochemistry of CD-68 and CD-163. Desmin immunohistochemistry showed significant muscle layer regeneration in the TCN (1% and 3%) patch groups. Moreover, sufficient re-epithelialization and neo-vascularization were affirmed in TCN (1% and 3%) patch groups. In this study, we confirmed that 3D-printed antibiotic-releasing patches not only have anti-microbial effects but also have tissue regeneration ability in the area surrounding the esophageal fistula site. The results of this study can be applied in further studies on tissue-engineering.식도 결손은 결손뢀에 λŒ€ν•œ λ‹€μ–‘ν•œ 세균총에 λŒ€ν•œ λ…ΈμΆœμ„ μœ λ°œν•˜λ©°, μ΄λŠ” μ‹¬ν•œ 염증 λ°˜μ‘μ„ μœ λ°œν•œλ‹€κ³  μ•Œλ €μ Έ μžˆλ‹€. μ €μž 및 연ꡬ진은 생뢄해성 polycaprolactone (PCL)을 μ‚¬μš©ν•˜μ—¬ 3D ν”„λ¦°ν„°λ‘œ 격자 λͺ¨μ–‘ 및 λ°•λ§‰μœΌλ‘œ κ΅¬μ„±λœ 패치λ₯Ό μ œμž‘ν•˜μ˜€κ³ , 여기에 ν•­μƒμ œ, tetracycline (TCN)이 방좜될 수 μžˆλ„λ‘ ν•˜μ—¬ 인곡적으둜 λ§Œλ“  식도 결손에 λŒ€ν•œ μž¬κ±΄μ„ μ‹œλ„ν•˜μ˜€λ‹€. 이후 정성적, μ •λŸ‰μ  뢄석을 톡해 패치의 ν™œμš©λ„μ™€ 효λŠ₯을 ν‰κ°€ν•˜μ˜€λ‹€. PCL은 미리 μž‘μ—…λœ 박막 μœ„μ— 100 ΞΌm ν•΄μƒλ„μ˜ 격자 λͺ¨μ–‘μœΌλ‘œ 3D ν”„λ¦°νŒ… ν•˜μ˜€μœΌλ©°, 100Β°Cμ—μ„œ 녹인 TCN와 PCL μž…μžλ₯Ό ν˜Όν•©ν•˜μ—¬ 3D ν”„λ¦°νŒ… ν•¨μœΌλ‘œμ¨ TCN이 νŒ¨μΉ˜μ—μ„œ 방좜될 수 μžˆλ„λ‘ ν•˜μ˜€λ‹€. μ²΄μ™Έμ‹€ν—˜μ—μ„œ TCN 은 1달 이상 μ§€μ†μ μœΌλ‘œ λ°©μΆœλ˜λŠ” 것을 확인할 수 μžˆμ—ˆμœΌλ©°, λ˜ν•œ 세포독성에 λŒ€ν•œ μ²΄μ™Έμ‹€ν—˜μ—μ„œ 패치 μΆ”μΆœλ¬Όμ΄ λ›°μ–΄λ‚œ 세포적합성을 λ³΄μž„μ„ 확인할 수 μžˆμ—ˆλ‹€. 이후 μ₯μ—μ„œ λΆ€λΆ„ 식도결손을 μœ λ°œν•œ ν›„ μ œμž‘λœ 패치λ₯Ό μ μš©ν•˜μ˜€κ³  3μ£Ό ν›„ micro CTλ₯Ό μ΄μš©ν•΄ λˆ„μΆœ μ—¬λΆ€λ₯Ό ν™•μΈν•˜μ˜€λ‹€. μ₯μ˜ ꡬ강을 톡해 쑰영제λ₯Ό μ£Όμ‚¬ν•˜μ—¬ ν™•μΈν•œ κ²°κ³Ό λͺ¨λ“  패치 μ΄μ‹κ΅°μ—μ„œ 식도 μ „μž₯에 λˆ„μΆœμ€ κ΄€μ°°λ˜μ§€ μ•Šμ•˜λ‹€. 수술 ν›„ 4μ£Ό 및 12주에 각각의 ꡰ을 ν¬μƒν•˜μ—¬ 쑰직학적 μž¬μƒ 정도λ₯Ό ν™•μΈν•œ κ²°κ³Ό, 1% 와 3% TCN 패치 κ·Έλ£Ήμ—μ„œ μœ μ˜λ―Έν•œ 근윑측 μž¬μƒμ΄ κ΄€μ°°λ˜μ—ˆκ³ , 면역쑰직화학염색 뢄석 κ²°κ³Ό, 1% 및 3% TCN 패치 κ·Έλ£Ήμ—μ„œ 재 상피화 및 μ΄μ‹λΆ€μœ„ μ£Όλ³€ μ‹ μƒν˜ˆκ΄€ 생성이 잘 이루어진 것을 확인할 수 μžˆμ—ˆλ‹€. λ³Έ μ—°κ΅¬μ—μ„œλŠ” 3D ν”„λ¦°νŒ…μ„ μ΄μš©ν•œ ν•­μƒμ œ 방좜 패치λ₯Ό ν™œμš©ν•˜μ˜€μ„ λ•Œ, TCN의 ν•­κ·  νš¨κ³Όμ™€ λ”λΆˆμ–΄ λˆ„κ³΅ μ£Όμœ„μ— 식도 κ·Όμœ‘μΈ΅μ„ λΉ„λ‘―ν•œ 쑰직 μž¬μƒμ—λ„ μΆ©λΆ„ν•œ νš¨κ³Όκ°€ μžˆμŒμ„ ν™•μΈν•˜μ˜€μœΌλ©° μ΄λŠ” μΆ”ν›„μ˜ μ—°κ΅¬μ—μ„œ 맀우 ν™œμš©μ„±μ΄ 높을 κ²ƒμœΌλ‘œ μƒκ°λœλ‹€.Chapter 1. Introduction 1 Chapter 2. Materials and Methods 4 Chapter 3. Results 15 Chapter 4. Discussion 24 Chapter 5. Conclusion 29 Tables and Figures 30 Bibliography 59 Abstract in Korean 64λ°•

    κ΅¬κ°•νŽΈν‰μ„Έν¬μ•”μ—μ„œ μ•”μ€„κΈ°μ„Έν¬ν‘œμ‹œμΈμž(CD24,44,133)κ³Ό 수술 ν›„ μ˜ˆν›„μ˜ 관계 뢄석

    Get PDF
    ν•™μœ„λ…Όλ¬Έ (석사)-- μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› μ˜κ³ΌλŒ€ν•™ μ˜ν•™κ³Ό, 2017. 8. μ•ˆμˆœν˜„.Introduction: Many studies have focused on the prognostic roles of cancer stem cell markers, but the results remain unclear. CD44 is the most well-known cancer stem cell marker in head and neck cancers, and CD24 and CD133 are representative cancer stem cell markers in many solid tumors. The aim of this study was to gain insight into the relationships between expression of CD24, CD44, and CD133, either alone or in combination, and prognostic parameters of oral squamous cell carcinoma (OSCC). Methods: Patients with OSCC who underwent successful surgical resection from January 2003 to December 2011 in a single tertiary hospital were included in this study. Tissue arrays composed of 67 primary tumor tissues were generated and used for immunohistochemistry (IHC) against CD24, CD44, and CD133. IHC was graded by a semiquantitative histologic scoring system (H score) that considered the extent and intensity of the staining. IHC results were correlated with clinicopathological characteristics and with clinical outcomes such as relapse-free, disease-free, and overall survivals. Results: In the 67 cases, the oral tongue was the most frequently affected primary site (56.7%). In tumor-lymph node-metastasis (TNM) staging, stage IV (34.3%) was most frequent, followed by stages I (26.9%), II (25.4%), and III (13.4%). Despite successful resection, there was 28.3% recurrence. TNM stage IV was highly related with the recurrence rate (p = 0.002). None of the 3 cancer stem cell markers (CD24, CD44, and CD133) had a statistically significant relationship with lymph node metastasis, TNM stage, or microscopic invasion into adjacent tissues. High expression of CD44 alone was associated with relapse-free survival (p=0.049), as were combined high expression of CD44 and CD133 (p=0.046) and CD44 and CD24 (p=0.015). CD44 expression also tended towards correlation with disease-free survivalhowever, this was not statistically significant (p=0.071). Conclusions: Overall, the expression of CD44 had the strongest correlation with tumor recurrence. Additionally, when CD44 expression was combined with CD24 expression, CD24+CD44+ patients had the poorest chance of relapse-free survival. Thus, CD44 expression alone, and also in combination with CD24, should be considered when evaluating the prognosis for relapse-free survival of OSCC.I. Introduction 1 II. Materials and Methods 2 III. Results 6 IV. Discussion 10 V. Conclusion 15 VI. References 37 VII. Abstract in Korean 41Maste

    ν•œ-EU, ν•œ-λ―Έ 무역ꡬ쑰 비ꡐ뢄석

    No full text
    ν•™μœ„λ…Όλ¬Έ (석사)-- μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› : κ΅­μ œν•™κ³Ό(κ΅­μ œμ§€μ—­ν•™μ „κ³΅), 2011.2. λ¬Έμš°μ‹.Maste

    건식에칭이 퍼말둜이 (Ni81Fe19) λ°•λ§‰μ˜ 자기적 νŠΉμ„±μ— λ―ΈμΉ˜λŠ” 영ν–₯

    No full text
    Thesis (doctoral)--μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› :κΈˆμ†κ³΅ν•™κ³Ό,1998.Docto

    Maximum entropy model-based intra-sentence segmentation for efficient syntactic analysis

    No full text
    ν•™μœ„λ…Όλ¬Έ(박사)--μ„œμšΈλŒ€ν•™κ΅ λŒ€ν•™μ› :컴퓨터곡학과,1999.Docto
    corecore